Why Private Equity Is Buying Up Independent Pharmacies
The Buyout Show with Fexingo · 2026-06-23 · 9 min
Episode notes
Episode 69 of The Buyout Show with Fexingo. Lucas and Luna examine the wave of private equity acquisitions of independent pharmacies, focusing on the specific strategy of roll-ups like the one led by Oak Street Health's former executives. They discuss the economics: how a single independent pharmacy generates roughly $3-5 million in revenue but only 8-12% EBITDA margins, and how consolidation into a 50-plus location entity can boost margins to 20% through centralized purchasing and back-office efficiencies. They also touch on the regulatory risks, including the FTC's recent scrutiny of pharmacy benefit manager practices. Hosts: Lucas and Luna. #PrivateEquity #Pharmacies #RollUps #IndependentPharmacy #OakStreetHealth #EBITDA #FTC #PBMs #PharmacyBenefitManagers #Consolidation #Healthcare #MergersAndAcquisitions #LBO #BusinessStrategy #FexingoBusiness #BusinessPodcast #TheBuyoutShow #RetailPharmacy Keep every episode free: buymeacoffee.com/fexingo
More from The Buyout Show with Fexingo
All episodes →- Why Private Equity Is Buying Up Wedding Venues47 / 100
- How Private Equity Is Buying Up Dermatology Practices39 / 100
- How Private Equity Is Buying Up Laundromats42 / 100
- How Private Equity Is Buying Up Marijuana Dispensaries
- How Private Equity Is Buying Up Security Guard Companies